newsfilter
← Latest News
GlobeNewswire·

ArriVent Announces a Multi-Target ADC Collaboration with Alphamab

Collaboration will leverage Alphamab's antibody drug conjugate ("ADC") research and discovery platform and ArriVent's global development and commercialization expertise Upfront and milestone payments to Alphamab worth